 Connection
Thomas Beresford to Cocaine-Related Disorders
This is a "connection" page, showing publications Thomas Beresford has written about Cocaine-Related Disorders.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.060 |
|
|
|
-
Beresford T, Buchanan J, Thumm EB, Emrick C, Weitzenkamp D, Ronan PJ. Late Reduction of Cocaine Cravings in a Randomized, Double-Blind Trial of Aripiprazole vs Perphenazine in Schizophrenia and Comorbid Cocaine Dependence. J Clin Psychopharmacol. 2017 Dec; 37(6):657-663.
Score: 0.544
-
Beresford TP, Clapp L, Martin B, Wiberg JL, Alfers J, Beresford HF. Aripiprazole in schizophrenia with cocaine dependence: a pilot study. J Clin Psychopharmacol. 2005 Aug; 25(4):363-6.
Score: 0.231
-
Clapp L, Martin B, Beresford TP. Sublingual cocaine: novel recurrence of an ancient practice. Clin Neuropharmacol. 2004 Mar-Apr; 27(2):93-4.
Score: 0.210
-
Kahn R, Biswas K, Childress AR, Shoptaw S, Fudala PJ, Gorgon L, Montoya I, Collins J, McSherry F, Li SH, Chiang N, Alathari H, Watson D, Liberto J, Beresford T, Stock C, Wallace C, Gruber V, Elkashef A. Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals. Drug Alcohol Depend. 2009 Jul 01; 103(1-2):59-64.
Score: 0.075
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|